Blogs / Hyundai Share Price ...

Hyundai Share Price Target 2025, 2026, 2027, 2030

2026-05-15 · 3 min read

Sector - Finance
Hyundai Share Price Target 2025, 2026, 2027, 2030


Hyundai Motor India Ltd is one of the most important automobile companies in India’s passenger vehicle market. 

Hyundai Share Price Target


For many Indian consumers, Hyundai is not just another car brand; it sits in that sweet spot between aspirational and practical. 

Financial table for Hyundai

Market Cap₹1,47,033 Cr.(As of May 2026)
Price to Earnings25.8
Return on equity42.2%
Debt to equity0.05
Current ratio1.33
Dividend Yield1.14%
Return on assets20.0%
ROCE54.2%
Face Value₹10.0
52 Week High₹2,890
52 Week Low₹1,658

Hyundai Shareholding Pattern



Mar 2025

Mar 2026

Promoters

82.50%

82.50%

FIIs

7.17%

5.43%

DIIs

7.00%

9.71%

Public

3.32%

2.37%

No. of Shareholders

11,51,436 

7,68,407 


Hyundai Price Target 2026, 2027, 2028 to 2030

YEAR 2026

Target Range (₹) : 2200-2800

for the move SUV demand and export growth support steady performance. Projected Targets:
YEAR 2027

Target Range (₹) : 2900-3200

for the move EV and hybrid growth support revenue expansion. Projected Targets:
YEAR 2028

Target Range (₹) : 3500-4000

for the move Export growth strengthens global positioning. Projected Targets:
YEAR 2029

Target Range (₹) : 3400-3600

for the move .SUV dominance supports stability. Projected Targets:
YEAR 2030

Target Range (₹) : 2900-3300

for the move Growth continues steadily with balanced mix.

Historic Performance:

Hyundai Share Price Target 2024 & 2025

YEAR 2024

Yearly returns : -6.61%

Start of the year price1,934.00
End of the year price1,806.10
Reason : Mild decline due to competitive pressure and margin concerns.
YEAR 2025

Yearly returns : 27.67%

Start of the year price1,800.00
End of the year price2,298.00
Reason : Strong recovery driven by SUV demand and export growth.

Conclusion

The Hyundai share price target depends on whether Hyundai Motor India can convert its brand strength into consistent earnings growth.

FAQs

To read the RA disclaimer, please click here